Clinical trial

Efficacy of Adding Low Dose Ketamine or Fentanyl to Propofol-dexmedetomidine as Total Intravenous Anesthesia for Patients Undergoing Craniotomy

Name
685-2023
Description
Efficacy of adding low dose ketamine or fentanyl to propofol-dexmedetomidine as total intravenous anesthesia for patients undergoing craniotomy in supra tentorial brain tumor
Trial arms
Trial start
2023-02-01
Estimated PCD
2024-04-01
Trial end
2024-04-01
Status
Recruiting
Phase
Early phase I
Treatment
Ketamine
Total intravenous anesthesia in craniotomy
Arms:
1, 2
Other names:
Fentanyl
Size
40
Primary endpoint
Evaluation of brain relaxation score
Intraoperative
Eligibility criteria
Inclusion Criteria: - Patients aged 18-70 years old ASA I - III with GCS 14-15 and BMI\<35 scheduled for elective craniotomy for resection of supratentorial masses Exclusion Criteria: * Patients will be excluded if they will refuse to give a written consent. Also patients with GCS \< 14 or having endocrine or blood diseases or sever cardiac disease or sever liver disease or renal failure and patients with uncontrolled hypertension or uncontrolled diabetes mellitus and patients have allergy to any of the study drugs.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE1', 'PHASE2'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'OTHER', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['INVESTIGATOR']}}, 'enrollmentInfo': {'count': 40, 'type': 'ESTIMATED'}}
Updated at
2024-03-08

1 organization

1 drug

1 indication

Organization
Minia University